Literature DB >> 6272939

3-mercaptopropionic acid inhibits GABA release from rat brain slices in vitro.

S G Fan, M Wusteman, L L Iversen.   

Abstract

3-Mercaptopropionic acid (3MP) (1 mM) inhibited the potassium-evoked release of endogenous GABA from slices of rat hippocampus and cerebral cortex in vitro. This did not appear to be due to an inhibition of GABA biosynthesis, since 3MP failed to affect the basal rate of GABA release or to accelerate the decline in the GABA content of tissue slices during prolonged exposure to 3MP (up to 120 min). 3MP, furthermore, inhibited the potassium-evoked release of [3H]GABA from preloaded brain slices, suggesting a direct inhibitory effect on GABA release. The threshold concentration was approximately 0.1 mM. 3MP at 1 mM failed to inhibit the potassium-evoked release of [3H]5-hydroxytryptamine, [3H]noradrenaline or somatostatin under similar conditions. The ability of 3MP to inhibit GABA release may contribute to the convulsant properties of this substance in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272939     DOI: 10.1016/0006-8993(81)91001-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Time course of effects of 3-mercaptopropionic acid on GABA levels in different brain regions in guinea pigs: possible relationship with associated cardiovascular changes.

Authors:  N L Alsip; J A DiMicco
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat.

Authors:  M Esclapez; S Trottier
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  An investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring.

Authors:  Eric W Crick; Ivan Osorio; Naresh C Bhavaraju; Thomas H Linz; Craig E Lunte
Journal:  Epilepsy Res       Date:  2007-03-26       Impact factor: 3.045

4.  The motor response to ethylenediamine of the rat isolated duodenum: involvement of GABAergic transmission?

Authors:  C A Maggi; S Giuliani; P Santicioli; S Selleri; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Microperfusion of 3-MPA into the brain augments GABA.

Authors:  Andrew P Mayer; Ivan Osorio; Craig E Lunte
Journal:  Epilepsy Behav       Date:  2013-10-02       Impact factor: 2.937

6.  Central GABA mechanisms during postnatal development in the rat: neurochemical characteristics.

Authors:  T Hedner; K Iversen; P Lundborg
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

7.  Evidence that ethylenediamine acts in the isolated ileum of the guinea-pig by releasing endogenous GABA.

Authors:  D I Kerr; J Ong
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

8.  Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices.

Authors:  Nese Dericioglu; Cheryl L Garganta; Ognen A Petroff; Dara Mendelsohn; Anne Williamson
Journal:  Neurochem Int       Date:  2008-04-22       Impact factor: 3.921

9.  Bicarbonate-dependence of responses to ethylenediamine in the guinea-pig isolated ileum: involvement of ethylenediamine-monocarbamate.

Authors:  D I Kerr; J Ong
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

10.  Effects of the glutamic acid decarboxylase inhibitor 3-mercaptopropionic acid on the synthesis of brain GABA in vivo and postmortally.

Authors:  S Lindgren
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.